Jubilant Pharmova Limited — Updates, 05-12-2025: General Updates
05-12-2025 | 04:48 pm
05-12-2025 | 04:48 pm
Jubilant Biosys, a subsidiary, faces a GST demand of ₹11.63 Cr (tax, interest, penalty) for alleged Input Tax Credit issues in FY22. The company plans to appeal, confident in its legal position, expecting no financial or operational impact.
No comments yet. Be the first to comment!
